Skip to content

Technology Enabled Services to Enhance Depression Care

Technology Enabled Services to Enhance Depression Care

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05406791
Enrollment
130
Registered
2022-06-06
Start date
2022-06-10
Completion date
2023-09-30
Last updated
2025-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety, Depression

Brief summary

This study will compare two digital mental health interventions (DMHIs). One DMHI will use an app called Vira (which is a product developed and managed by Ksana Health), along with low intensity coaching provided via phone and both SMS text and in-app messaging. The other DMHI will provide a broad range of information on how to manage symptoms of depression, anxiety, and stress. The DMHI will be evaluated with patients receiving care from Rush University Medical Center's primary care and family medicine clinics, which serve racially, ethnically, and economically diverse communities; evaluations may also be extended beyond Rush patients.

Detailed description

Depression and anxiety are common and impose a tremendous societal burden in terms of cost, morbidity, quality of life, and mortality. Yet, few people are able to obtain adequate or appropriate treatment. This trial will compare the ability of two digital mental health interventions (DMHIs) to reduce depression and anxiety. One DMHI, called Mood Education App, provides information on depression and a broad range of strategies that are effective in improving symptoms. The other app, called VIRA, uses smartphone sensors to identify a few behavioral markers, including mobility patterns, physical activity, and sleep. The results of these sensed behavioral markers are used to give the participant behavior change recommendations through the Vira app that are expected to result in symptom improvement. The DMHI will include low intensity coaching, which includes one or more brief phone calls and communication via SMS text and in-app messaging. Both treatments are 8-weeks long. The trial will be conducted within Rush University Medical Center's primary care and family medicine clinics, although recruitment be expanded beyond these clinics.

Interventions

OTHERVIRA App

Support from coach and using the VIRA app

OTHERMood Education App

Support from mood education app

Sponsors

Rush University
CollaboratorOTHER
National Institute of Mental Health (NIMH)
CollaboratorNIH
Northwestern University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Randomized Controlled Trial

Eligibility

Sex/Gender
ALL
Age
13 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* US Citizen/ Resident * 13 years or older * English Speaking * Owns an Android or iPhone smartphone with an up-to-date operating system * Has used a smartphone in the last 7 days * PHQ-8 greater than or equal to 10 and/or GAD-7 greater than or equal to 10

Exclusion criteria

* Children under the age of 13 * Severe suicidality (as defined by presence of a plan + intent to act on that plan)

Design outcomes

Primary

MeasureTime frameDescription
Patient Health Questionaire-9 (PHQ-9)12 weeksThe PHQ-9 measures depression symptom severity on a scale of 0-27, with higher scores indicating greater symptom severity.
Generalized Anxiety Disorder-7 (GAD-7)12 weeksThe GAD-7 measures anxiety symptom severity on a scale of 0-21, with higher scores indicating greater symptoms severity

Countries

United States

Participant flow

Recruitment details

Recruitment took place between June 2022 and June 2023. Patients were recruited in-person from clinic-based sites and through community events (e.g., back-to-school fairs, wellness events); the electronic health record (EHR; MyChart/Epic); social media and other platforms; and through subject recruitment registries.

Pre-assignment details

Of 258 individuals assessed for eligibility, 130 met inclusion criteria and were randomized to treatment groups.

Participants by arm

ArmCount
Sensor-enabled Digital Mental Health Intervention (DMHI)
Patients randomized to sensor-enabled DMHI condition will use Ksana Health's Vira mobile therapy platform with support from a study coach VIRA App: Support from coach and using the VIRA app
65
Experimental: Control Treatment (CT)
Participants randomized to the CT condition will use a Mood Education App designed by researchers at the University of Virginia to deliver psychoeducational content to help people self-manage symptoms of depression, anxiety, and stress. Mood Education App: Support from mood education app
65
Total130

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyLost to Follow-up1310

Baseline characteristics

CharacteristicSensor-enabled Digital Mental Health Intervention (DMHI)Experimental: Control Treatment (CT)Total
Age, Categorical
<=18 years
3 Participants3 Participants6 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
62 Participants62 Participants124 Participants
Age, Continuous30 years33 years32 years
Education
Bachelor's Degree
18 Participants17 Participants35 Participants
Education
High School Graduate/ GED
6 Participants5 Participants11 Participants
Education
Post-Bachelors Education
19 Participants24 Participants43 Participants
Education
Prefer not to answer
0 Participants1 Participants1 Participants
Education
Some high school or less
4 Participants3 Participants7 Participants
Education
Vocational/Technical Degree, Associate's Degree, or Some College
18 Participants15 Participants33 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
12 Participants16 Participants28 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
53 Participants48 Participants101 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants1 Participants1 Participants
Household Income
$100,000 +
20 Participants23 Participants43 Participants
Household Income
$10,000 - $19,999
4 Participants9 Participants13 Participants
Household Income
$20,000 - $39,999
7 Participants5 Participants12 Participants
Household Income
$40,000 - $59,999
7 Participants2 Participants9 Participants
Household Income
$60,000 - $99,999
14 Participants14 Participants28 Participants
Household Income
Don't know
4 Participants6 Participants10 Participants
Household Income
Less than $10,000
6 Participants3 Participants9 Participants
Household Income
Prefer not to answer
3 Participants3 Participants6 Participants
Marital Status
Divorced
2 Participants0 Participants2 Participants
Marital Status
Living with Partner
8 Participants10 Participants18 Participants
Marital Status
Married
17 Participants15 Participants32 Participants
Marital Status
Separated
0 Participants2 Participants2 Participants
Marital Status
Single
37 Participants37 Participants74 Participants
Marital Status
Widowed
1 Participants1 Participants2 Participants
Race (NIH/OMB)
American Indian or Alaska Native
1 Participants1 Participants2 Participants
Race (NIH/OMB)
Asian
5 Participants5 Participants10 Participants
Race (NIH/OMB)
Black or African American
18 Participants15 Participants33 Participants
Race (NIH/OMB)
More than one race
6 Participants9 Participants15 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants2 Participants2 Participants
Race (NIH/OMB)
White
35 Participants33 Participants68 Participants
Region of Enrollment
United States
65 participants65 participants130 participants
Sex: Female, Male
Female
53 Participants53 Participants106 Participants
Sex: Female, Male
Male
12 Participants12 Participants24 Participants
Sex/Gender, Customized
Female
52 Participants49 Participants101 Participants
Sex/Gender, Customized
Male
12 Participants12 Participants24 Participants
Sex/Gender, Customized
Non-binary
0 Participants4 Participants4 Participants
Sex/Gender, Customized
Transgender
1 Participants0 Participants1 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 650 / 65
other
Total, other adverse events
0 / 650 / 65
serious
Total, serious adverse events
0 / 650 / 65

Outcome results

Primary

Generalized Anxiety Disorder-7 (GAD-7)

The GAD-7 measures anxiety symptom severity on a scale of 0-21, with higher scores indicating greater symptoms severity

Time frame: 12 weeks

ArmMeasureGroupValue (LEAST_SQUARES_MEAN)
Sensor-enabled Digital Mental Health Intervention (DMHI)Generalized Anxiety Disorder-7 (GAD-7)Baseline11.7 score on a scale
Sensor-enabled Digital Mental Health Intervention (DMHI)Generalized Anxiety Disorder-7 (GAD-7)Week 48.8 score on a scale
Sensor-enabled Digital Mental Health Intervention (DMHI)Generalized Anxiety Disorder-7 (GAD-7)Week 88.2 score on a scale
Sensor-enabled Digital Mental Health Intervention (DMHI)Generalized Anxiety Disorder-7 (GAD-7)Week 127.5 score on a scale
Experimental: Control Treatment (CT)Generalized Anxiety Disorder-7 (GAD-7)Week 127.4 score on a scale
Experimental: Control Treatment (CT)Generalized Anxiety Disorder-7 (GAD-7)Baseline12.2 score on a scale
Experimental: Control Treatment (CT)Generalized Anxiety Disorder-7 (GAD-7)Week 89.3 score on a scale
Experimental: Control Treatment (CT)Generalized Anxiety Disorder-7 (GAD-7)Week 49.8 score on a scale
Primary

Patient Health Questionaire-9 (PHQ-9)

The PHQ-9 measures depression symptom severity on a scale of 0-27, with higher scores indicating greater symptom severity.

Time frame: 12 weeks

ArmMeasureGroupValue (LEAST_SQUARES_MEAN)
Sensor-enabled Digital Mental Health Intervention (DMHI)Patient Health Questionaire-9 (PHQ-9)Baseline13.2 score on a scale
Sensor-enabled Digital Mental Health Intervention (DMHI)Patient Health Questionaire-9 (PHQ-9)Week 89.5 score on a scale
Sensor-enabled Digital Mental Health Intervention (DMHI)Patient Health Questionaire-9 (PHQ-9)Week 410.0 score on a scale
Sensor-enabled Digital Mental Health Intervention (DMHI)Patient Health Questionaire-9 (PHQ-9)Week 128.7 score on a scale
Experimental: Control Treatment (CT)Patient Health Questionaire-9 (PHQ-9)Week 49.4 score on a scale
Experimental: Control Treatment (CT)Patient Health Questionaire-9 (PHQ-9)Baseline12.4 score on a scale
Experimental: Control Treatment (CT)Patient Health Questionaire-9 (PHQ-9)Week 127.9 score on a scale
Experimental: Control Treatment (CT)Patient Health Questionaire-9 (PHQ-9)Week 89.2 score on a scale

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026